C07D 269/00
Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom
Official title: Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
C07D269/00 (Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom) appears on 15 US grants and 16 published applications in this corpus.
Search patents in C07D- Granted patents
- 15
- Published applications
- 16
- Assignees
- 13
- Inventors
- 51
- Latest grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 3 | 1 |
| 2017 | 2 | 2 |
| 2018 | 2 | 3 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Heterocycle amines and uses thereof3 Oct 2023US 11,773,110 B2Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof30 Nov 2021US 11,186,593 B2Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof31 Mar 2020US 10,604,533 B2Ligand Pharmaceuticals Incorporated
- Compounds and methods for the treatment of neurodegenerative diseases5 Nov 2019US 10,464,883 B2Resilio Therapeutics, LLC
- Heterocycle amines and uses thereof24 Jul 2018US 10,030,034 B2Ligand Pharmaceuticals Incorporated
- Arylamine organic compound and use thereof20 Jun 2024US 2024/0199559 A1Guangzhou Chinaray Optoelectronic Materials Ltd.
- Heterocycle amines and uses thereof21 Apr 2022US 2022/0119413 A1Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof9 Jul 2020US 2020/0216468 A1Ligand Pharmaceuticals Incorporated
- Heterocycle amines and uses thereof18 Oct 2018US 2018/0298031 A1Ligand Pharmaceuticals Incorporated
- Compounds and methods for the treatment of neurodegenerative diseases3 May 2018US 2018/0118661 A1Resilio Therapeutics, LLC
Most cited
By later US patents
- O-substituted hydroxyaryl derivatives19US 7,626,042 B2Institute of Medicinal Molecular Design, Inc. · 2009
- Heterocycle amines and uses thereof5US 10,030,034 B2Ligand Pharmaceuticals Incorporated · 2018
- Sonic hedgehog modulators2US 8,530,456 B2Massachusetts Institute of Technology · 2013
- Heterocycle amines and uses thereof2US 9,266,874 B2Ligand Pharmaceuticals Incorporated · 2016
- Compounds and methods for the treatment of neurodegenerative diseases1US 10,464,883 B2Resilio Therapeutics, LLC · 2019